2076975 2077203
최종편집 2024-04-19 17:22 (금)
BMS psoriasis treatment Sotyktu lands in Korea
상태바
BMS psoriasis treatment Sotyktu lands in Korea
  • Hyeokgi Lee, Newsmp
  • 승인 2023.08.08 00:10
  • 댓글 0
이 기사를 공유합니다

[Newsmp] The Ministry of Food and Drug Safety on the 3rd announced the approval of the new psoriasis drug Sotyktu (ingredient: deucravacitinib) imported by BMS Korea.

Sotyktu is an oral psoriasis drug that selectively targets and inhibits TYK2, a protein that plays a key role in the immune system.

"We expect that this drug will provide a new treatment opportunity for adults with moderate to severe plaque psoriasis who need phototherapy or systemic therapy," said the representative at MFDS. “We will continue to do our best to ensure that safe and effective treatments are available to patients as quickly as possible, based on our regulatory science expertise.”


댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
댓글쓰기
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.